Volume 36, Issue 5

Search all Cardiovascular Drugs and Therapy articles

October 2022

Supplement: Evolving Roles of Optimal Medical Therapy and PCI in Chronic Coronary Syndrome Patients with Stable Angina (pages 1005 - 1045)

Issue Editors:

William Boden,
Juan Carlos Kaski

24 articles in this issue

Early Myocardial Dysfunction and Benefits of Cardiac Treatment in Young X-Linked Duchenne Muscular Dystrophy Mice
Marie Vincenti
Charlotte Farah
Olivier Cazorla
Original Article 17 June 2021 Pages: 793 - 803
Mirabegron Ameliorated Atherosclerosis of ApoE^−/− Mice in Chronic Intermittent Hypoxia but Not in Normoxia
Yue Wang
Yue Wang
Xiao-fan Wu
Original Article 21 June 2021 Pages: 805 - 815
The IL-6/STAT Signaling Pathway and PPARα Are Involved in Mediating the Dose-Dependent Cardioprotective Effects of Fenofibrate in 5-Fluorouracil-Induced Cardiotoxicity
Marwa M. M. Refaie
Sayed Shehata
Walaa Yehia Abdelzaher
Original Article 29 June 2021 Pages: 817 - 827
Ticagrelor and Dapagliflozin Have Additive Effects in Ameliorating Diabetic Nephropathy in Mice with Type-2 Diabetes Mellitus
Yochai Birnbaum
Huan Chen
Yumei Ye
Original Article 07 July 2021 Pages: 829 - 840
Morphine Prevents Ischemia/Reperfusion-Induced Myocardial Mitochondrial Damage by Activating δ-opioid Receptor/EGFR/ROS Pathway
Jingman Xu
Xiyun Bian
Wei Tian
Original Article 19 July 2021 Pages: 841 - 857
Effect of Paclitaxel-Coated Balloon Angioplasty on Side Branch Lesion and Cardiovascular Outcomes in Patients with De Novo True Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
Youmei Li
Qi Mao
Jianhua Zhao
Original Article 09 July 2021 Pages: 859 - 866
Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy Data
Stella Talic
Clara Marquina
Zanfina Ademi
Original Article 07 June 2021 Pages: 867 - 877
An Adapted Neural-Fuzzy Inference System Model Using Preprocessed Balance Data to Improve the Predictive Accuracy of Warfarin Maintenance Dosing in Patients After Heart Valve Replacement
Zhi-Chun Gu
Shou-Rui Huang
Jin Chen
Original Article 20 April 2021 Pages: 879 - 889
Arrhythmia Recurrence After Atrial Fibrillation Ablation: Impact of Warfarin vs. Non-Vitamin K Antagonist Oral Anticoagulants
Songnan Wen
Cristina Pislaru
Samuel J. Asirvatham
Original Article 18 May 2021 Pages: 891 - 901
Effects of Major Antihypertensive Drug Classes on Erectile Function: a Network Meta-analysis
Ioannis T. Farmakis
Nikolaos Pyrgidis
George Giannakoulas
Original Article 04 May 2021 Pages: 903 - 914
Five Years of Sacubitril/Valsartan—a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance
Yee Soo Kim
Simerjeet Brar
Sourbha S. Dani
Original Article 14 June 2021 Pages: 915 - 924
RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
Sean M. Davidson
Kishal Lukhna
Derek M. Yellon
Original Article Open access 25 June 2021 Pages: 925 - 930
Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
Sean M. Davidson
Kishal Lukhna
Derek M. Yellon
Correction 07 July 2021 Pages: 931 - 931
Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell–Derived Microvesicles to Repair the Ischemic Heart
Gemma Vilahur
Phuong Hue Nguyen
Lina Badimon
Review Article 12 July 2021 Pages: 933 - 949
Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis
Ioannis Doundoulakis
Maria Gavriilaki
Konstantinos Tsioufis
Review Article 05 June 2021 Pages: 951 - 958
Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease
Waleed AlHabeeb
Sanaa Mrabeti
Ahmed Adel Ibrahim Abdelsalam
Review Article Open access 09 June 2021 Pages: 959 - 971
Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants
Robert Benamouzig
Maxime Guenoun
Laurent Fauchier
Review Article 18 June 2021 Pages: 973 - 989
Efficacy and Safety of Low-Dose Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis
Yuttana Wongsalap
Supakorn Ungsriwong
Kirati Kengkla
Original Article 25 June 2021 Pages: 991 - 1000
Opioids in Acute Coronary Syndromes: Friend or Foe?
Maryna V. Basalay
Derek M. Yellon
Sean M. Davidson
Invited Editorial 06 July 2022 Pages: 1001 - 1003
Evolving Roles of Optimal Medical Therapy and PCI in Chronic Coronary Syndrome Patients with Stable Angina: Introduction
William E. Boden
Juan Carlos Kaski
Invited Review Article 19 July 2022 Pages: 1005 - 1009
Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding
Alexandra N Nowbar
Darrel P Francis
Rasha K Al-Lamee
Invited Review Article Open access 21 August 2021 Pages: 1011 - 1018
The Impact of the ISCHEMIA Trial on Clinical Practice: an Interventionist’s Perspective
Kreton Mavromatis
Anthony Gershlick
Invited Review Article 29 July 2021 Pages: 1019 - 1026
What Is the Role of Assessing Ischemia to Optimize Therapy and Outcomes for Patients with Stable Angina and Non-obstructed Coronary Arteries?
Colin Berry
Andrew J. Morrow
Carl J. Pepine
Invited Review Article Open access 12 May 2021 Pages: 1027 - 1038
Optimal Medical Therapy as First-Line Therapy for Chronic Coronary Syndromes: Lessons from COURAGE, BARI 2D, FAME 2, and ISCHEMIA
David L. Brown
Invited Review Article 12 November 2021 Pages: 1039 - 1045

Volume 36, Issue 5

Search

Navigation